An ARDC case study

Enabling researchers to access and share data from health studies

In partnership with the health research community, the ARDC is establishing national infrastructure to enable researchers to access and share data from health studies, with an initial focus on clinical trials.

The initiative aims to stimulate new data-driven research ideas, increase the impact of health research and ultimately improve the health and wellbeing of Australians.

The potential of sharing health research study data

A wealth of data is created through health research studies, including information about the people taking part in the research, their health and their response to interventions being studied.

The data collected in one study is extremely valuable to other studies. However, the challenges of patient privacy and the naturally siloed approaches of research groups and state jurisdictions have created a confusing array of inadequate options and cottage-industry approaches to data sharing. The ARDC is playing a critical role in partnership with the health research community to synchronise efforts, align approaches and build national data capability.

This untapped trove of health research data will bring immense value to health research, maximising the return on investment of past research and allowing future research to build upon it to improve health outcomes for Australians.

Similar capability has already been established in European health research infrastructure (ECRIN and EOSC Life) and data sharing platforms are emerging in the UK and USA. Australia risks being left behind without a corresponding capability.

Collaborating to maximise the value of data

The Advisory Committee for the initiative includes key national health research organisations:

  • Australian Clinical Trials Alliance (ACTA)
  • Australian Health Research Alliance (AHRA)
  • Australian New Zealand Clinical Trials Registry (ANZCTR)
  • Cochrane Australia
  • Consumers Health Forum of Australia (CHF)
  • National Health & Medical Research Council (NHMRC)
  • Population Health Research Network (PHRN)
  • Research Australia

Systematic consultation to build consensus

Informed by the NCRIS facilitation process, the HeSANDA initiative implemented an 18-month systematic consultation and co-design process with assistance from the Australian Institute of Health and Welfare (AIHW), clinical trialists, researchers, health consumers and research institutions, as well as infrastructure providers and policy makers involved in clinical trials research. This established consensus around the purpose, content and requirements for a national health data asset to be created through the HeSANDA initiative, summarised in Figure 1:

HeSANDA Infrastructure Model
Figure 1: HeSANDA infrastructure model

Creating the national data asset

In June 2021, the HeSANDA initiative hit a significant milestone with confirmation of 9 initial nodes of a nationally distributed network of health data sharing infrastructure.

These 9 initial nodes confirm a broad national participation covering 72 health research organisations including:

  • medical18 universities, 10 medical research institutes, 19 health service operators, 16 clinical trial networks and 9 other organisations
  • All Australian states and territories with the exception of Tasmania and the ACT
  • Considerable depth in several specialised fields of health research:
  • The National Cooperative Cancer Trials Group node represents the 14 major cancer clinical trials networks in Australia
  • The Mental Health node includes nascent clinical trials networks spanning major universities, medical research institutes and health services conducting research into adult, child and youth mental health
  • The Northern Australian node provides national leadership in Aboriginal and Torres Strait Islander health research and international leadership in tropical medicine and disease research.

The infrastructure build phase of this 9-node network commences in Q3 2021 with coordinated design, implementation and testing. The initial rollout of the data asset will contain clinical trials data generated from >$56 million of public investment from the NHMRC and MRFF.

Translating infrastructure into benefit

The broad alliance of partners in the HeSANDA initiative are committed to translational research. Together they have a demonstrated track record of translating health research into positive changes to:

  • Patient health apps (e.g. for diabetes management)
  • Australian health guidelines (e.g. pregnancy guidelines to reduce the risk of prematurity)
  • World Health Organisation guidelines (e.g. WHO malaria, cancer and essential medicines guidelines)
  • Decision-support on the clinical floor (e.g. evaluating AI support for clinicians).

The new HeSANDA data sharing capability put in place by these node partners is designed to accelerate and transform such activities by providing a robust and coordinated national infrastructure.

medical

 

“The Australian Health Research Alliance (AHRA) across our ten NHMRC accredited Centres, integrates healthcare, research and education to deliver better health. Our priorities include improving data standards, governance, access and use for research and healthcare improvement. We strongly support, and are partnering to deliver, the aims of HeSANDA, with nodes across Australia to enhance collaboration, knowledge and technology exchange, capability building and delivery of impact through better use of data.”

  • Professor Helena Teede MBBS PhD FRACP FAAHMS FRANZCOG
    Chair of AHRA's Data-Driven Healthcare Improvement Committee
    Executive Director Monash Partners Academic Health Science Centre
    Professor of Women’s Health and Director Monash Centre for Health Research and Implementation, School Public Health, Monash University
    Chair of the National Women’s Health Research, Translation and Impact Network
    Endocrinologist Monash Health

Forward Roadmap

Phase 1 of the HeSANDA initiative has 9 nodes focused on clinical trials; future phases of the initiative are designed to include more nodes and support high value data from other health study types such as clinical registries or cohort studies.

medical

 

“ARDC has taken a highly collaborative approach to the HeSANDA initiative and we are glad to both represent and help capture the voice of the investigator-led clinical trials sector. ACTA supports the ethical, feasible and valid sharing of clinical trials data for use in further research, toward better health through best evidence.”

  • Prof Steve Webb, Chair of the Australian Clinical Trials Alliance (ACTA)

 

Related resources